Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Detecting maternal-fetal genotype interactions associated with conotruncal heart defects: a haplotype-based analysis with penalized logistic regression.

Li M, Erickson SW, Hobbs CA, Li J, Tang X, Nick TG, Macleod SL, Cleves MA; National Birth Defect Prevention Study.

Genet Epidemiol. 2014 Apr;38(3):198-208. doi: 10.1002/gepi.21793. Epub 2014 Mar 2.

2.

A genetic association study detects haplotypes associated with obstructive heart defects.

Li M, Cleves MA, Mallick H, Erickson SW, Tang X, Nick TG, Macleod SL, Hobbs CA; National Birth Defect Prevention Study.

Hum Genet. 2014 Sep;133(9):1127-38. doi: 10.1007/s00439-014-1453-1. Epub 2014 Jun 4.

3.

Maternal obesity and tobacco use modify the impact of genetic variants on the occurrence of conotruncal heart defects.

Tang X, Nick TG, Cleves MA, Erickson SW, Li M, Li J, MacLeod SL, Hobbs CA.

PLoS One. 2014 Oct 2;9(9):e108903. doi: 10.1371/journal.pone.0108903. eCollection 2014.

4.

A Three-Way Interaction among Maternal and Fetal Variants Contributing to Congenital Heart Defects.

Li M, Li J, Wei C, Lu Q, Tang X, Erickson SW, MacLeod SL, Hobbs CA.

Ann Hum Genet. 2016 Jan;80(1):20-31. doi: 10.1111/ahg.12139. Epub 2015 Nov 27.

5.

Conotruncal heart defects and common variants in maternal and fetal genes in folate, homocysteine, and transsulfuration pathways.

Hobbs CA, Cleves MA, Macleod SL, Erickson SW, Tang X, Li J, Li M, Nick T, Malik S; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2014 Feb;100(2):116-26. doi: 10.1002/bdra.23225. Epub 2014 Feb 18.

6.

118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects.

Shaw GM, Lu W, Zhu H, Yang W, Briggs FB, Carmichael SL, Barcellos LF, Lammer EJ, Finnell RH.

BMC Med Genet. 2009 Jun 3;10:49. doi: 10.1186/1471-2350-10-49.

7.

Maternal-fetal metabolic gene-gene interactions and risk of neural tube defects.

Lupo PJ, Mitchell LE, Canfield MA, Shaw GM, Olshan AF, Finnell RH, Zhu H; National Birth Defects Prevention Study.

Mol Genet Metab. 2014 Jan;111(1):46-51. doi: 10.1016/j.ymgme.2013.11.004. Epub 2013 Nov 18.

8.

Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes.

Shaw GM, Iovannisci DM, Yang W, Finnell RH, Carmichael SL, Cheng S, Lammer EJ.

Am J Med Genet A. 2005 Sep 15;138(1):21-6.

PMID:
16100725
9.

Mapping haplotype-haplotype interactions with adaptive LASSO.

Li M, Romero R, Fu WJ, Cui Y.

BMC Genet. 2010 Aug 27;11:79. doi: 10.1186/1471-2156-11-79.

10.

Common 894G>T single nucleotide polymorphism in the gene coding for endothelial nitric oxide synthase (eNOS) and risk of congenital heart defects.

van Beynum IM, Mooij C, Kapusta L, Heil S, den Heijer M, Blom HJ.

Clin Chem Lab Med. 2008;46(10):1369-75. doi: 10.1515/CCLM.2008.271.

PMID:
18844489
11.

The Quantitative-MFG Test: A Linear Mixed Effect Model to Detect Maternal-Offspring Gene Interactions.

Clark MM, Blangero J, Dyer TD, Sobel EM, Sinsheimer JS.

Ann Hum Genet. 2016 Jan;80(1):63-80. doi: 10.1111/ahg.12137. Epub 2015 Nov 15.

12.

Obstructive heart defects associated with candidate genes, maternal obesity, and folic acid supplementation.

Tang X, Cleves MA, Nick TG, Li M, MacLeod SL, Erickson SW, Li J, Shaw GM, Mosley BS, Hobbs CA; National Birth Defects Prevention Study.

Am J Med Genet A. 2015 Jun;167(6):1231-42. doi: 10.1002/ajmg.a.36867. Epub 2015 Apr 2.

13.

Maternal and fetal variation in genes of cholesterol metabolism is associated with preterm delivery.

Steffen KM, Cooper ME, Shi M, Caprau D, Simhan HN, Dagle JM, Marazita ML, Murray JC.

J Perinatol. 2007 Nov;27(11):672-80. Epub 2007 Sep 13.

14.

Genetic variation affects congenital heart defect susceptibility in offspring exposed to maternal tobacco use.

Tang X, Hobbs CA, Cleves MA, Erickson SW, MacLeod SL, Malik S; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2015 Oct;103(10):834-42. doi: 10.1002/bdra.23370. Epub 2015 Jun 2.

15.

Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia.

Parimi N, Tromp G, Kuivaniemi H, Nien JK, Gomez R, Romero R, Goddard KA.

BMC Med Genet. 2008 Jul 3;9:60. doi: 10.1186/1471-2350-9-60.

16.

NAT1, NOS3, and TYMS genotypes and the risk of conotruncal cardiac defects.

Lupo PJ, Mitchell LE, Goldmuntz E.

Birth Defects Res A Clin Mol Teratol. 2011 Jan;91(1):61-5. doi: 10.1002/bdra.20745. Epub 2010 Dec 1.

17.

Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study.

Nembhard WN, Tang X, Hu Z, MacLeod S, Stowe Z, Webber D; National Birth Defects Prevention Study.

BMJ. 2017 Mar 6;356:j832. doi: 10.1136/bmj.j832.

18.

Detecting genotype combinations that increase risk for disease: maternal-fetal genotype incompatibility test.

Sinsheimer JS, Palmer CG, Woodward JA.

Genet Epidemiol. 2003 Jan;24(1):1-13.

PMID:
12508251
19.

Evaluation of heterogeneity in the association between congenital heart defects and variants of folate metabolism genes: conotruncal and left-sided cardiac defects.

Long J, Lupo PJ, Goldmuntz E, Mitchell LE.

Birth Defects Res A Clin Mol Teratol. 2011 Oct;91(10):879-84. doi: 10.1002/bdra.22849. Epub 2011 Aug 24.

20.

Genetic variation of infant reduced folate carrier (A80G) and risk of orofacial and conotruncal heart defects.

Shaw GM, Zhu H, Lammer EJ, Yang W, Finnell RH.

Am J Epidemiol. 2003 Oct 15;158(8):747-52.

PMID:
14561664

Supplemental Content

Support Center